Global Spinal Muscular Atrophy Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Spinal Muscular Atrophy market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spinal Muscular Atrophy development in United States, Europe and China.
    
    The key players covered in this study
        Lonis Pharmaceuticals
        F. Hoffmann-La Roche
        AveXis
        Novartis
        Cytokinetics
        Ionis Pharmaceuticals
        ...
    
    Market segment by Type, the product can be split into
        Early Stage Candidates
        Late Stage Candidates
    
    Market segment by Application, split into
        Hospital
        Clinic
        Others
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players.
        To present the Spinal Muscular Atrophy development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Spinal Muscular Atrophy are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type (2013-2025)
            1.4.2 Early Stage Candidates
            1.4.3 Late Stage Candidates
        1.5 Market by Application
            1.5.1 Global Spinal Muscular Atrophy Market Share by Application (2013-2025)
            1.5.2 Hospital
            1.5.3 Clinic
            1.5.4 Others
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Spinal Muscular Atrophy Market Size
        2.2 Spinal Muscular Atrophy Growth Trends by Regions
            2.2.1 Spinal Muscular Atrophy Market Size by Regions (2013-2025)
            2.2.2 Spinal Muscular Atrophy Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Spinal Muscular Atrophy Market Size by Manufacturers
            3.1.1 Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018)
            3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
        3.2 Spinal Muscular Atrophy Key Players Head office and Area Served
        3.3 Key Players Spinal Muscular Atrophy Product/Solution/Service
        3.4 Date of Enter into Spinal Muscular Atrophy Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018)
        4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Spinal Muscular Atrophy Market Size (2013-2018)
        5.2 Spinal Muscular Atrophy Key Players in United States
        5.3 United States Spinal Muscular Atrophy Market Size by Type
        5.4 United States Spinal Muscular Atrophy Market Size by Application
    
    6 Europe
        6.1 Europe Spinal Muscular Atrophy Market Size (2013-2018)
        6.2 Spinal Muscular Atrophy Key Players in Europe
        6.3 Europe Spinal Muscular Atrophy Market Size by Type
        6.4 Europe Spinal Muscular Atrophy Market Size by Application
    
    7 China
        7.1 China Spinal Muscular Atrophy Market Size (2013-2018)
        7.2 Spinal Muscular Atrophy Key Players in China
        7.3 China Spinal Muscular Atrophy Market Size by Type
        7.4 China Spinal Muscular Atrophy Market Size by Application
    
    8 Japan
        8.1 Japan Spinal Muscular Atrophy Market Size (2013-2018)
        8.2 Spinal Muscular Atrophy Key Players in Japan
        8.3 Japan Spinal Muscular Atrophy Market Size by Type
        8.4 Japan Spinal Muscular Atrophy Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018)
        9.2 Spinal Muscular Atrophy Key Players in Southeast Asia
        9.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type
        9.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application
    
    10 India
        10.1 India Spinal Muscular Atrophy Market Size (2013-2018)
        10.2 Spinal Muscular Atrophy Key Players in India
        10.3 India Spinal Muscular Atrophy Market Size by Type
        10.4 India Spinal Muscular Atrophy Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Spinal Muscular Atrophy Market Size (2013-2018)
        11.2 Spinal Muscular Atrophy Key Players in Central & South America
        11.3 Central & South America Spinal Muscular Atrophy Market Size by Type
        11.4 Central & South America Spinal Muscular Atrophy Market Size by Application
    
    12 International Players Profiles
        12.1 Lonis Pharmaceuticals
            12.1.1 Lonis Pharmaceuticals Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Spinal Muscular Atrophy Introduction
            12.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)
            12.1.5 Lonis Pharmaceuticals Recent Development
        12.2 F. Hoffmann-La Roche
            12.2.1 F. Hoffmann-La Roche Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Spinal Muscular Atrophy Introduction
            12.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)
            12.2.5 F. Hoffmann-La Roche Recent Development
        12.3 AveXis
            12.3.1 AveXis Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Spinal Muscular Atrophy Introduction
            12.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)
            12.3.5 AveXis Recent Development
        12.4 Novartis
            12.4.1 Novartis Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Spinal Muscular Atrophy Introduction
            12.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)
            12.4.5 Novartis Recent Development
        12.5 Cytokinetics
            12.5.1 Cytokinetics Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Spinal Muscular Atrophy Introduction
            12.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)
            12.5.5 Cytokinetics Recent Development
        12.6 Ionis Pharmaceuticals
            12.6.1 Ionis Pharmaceuticals Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Spinal Muscular Atrophy Introduction
            12.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)
            12.6.5 Ionis Pharmaceuticals Recent Development
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Spinal Muscular Atrophy Key Market Segments
        Table Key Players Spinal Muscular Atrophy Covered
        Table Global Spinal Muscular Atrophy Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Spinal Muscular Atrophy Market Size Market Share by Type 2013-2025
        Figure Early Stage Candidates Figures
        Table Key Players of Early Stage Candidates
        Figure Late Stage Candidates Figures
        Table Key Players of Late Stage Candidates
        Table Global Spinal Muscular Atrophy Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospital Case Studies
        Figure Clinic Case Studies
        Figure Others Case Studies
        Figure Spinal Muscular Atrophy Report Years Considered
        Table Global Spinal Muscular Atrophy Market Size 2013-2025 (Million US$)
        Figure Global Spinal Muscular Atrophy Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2025 (Million US$)
        Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2018 (Million US$)
        Table Global Spinal Muscular Atrophy Market Share by Regions 2013-2018
        Figure Global Spinal Muscular Atrophy Market Share by Regions 2013-2018
        Figure Global Spinal Muscular Atrophy Market Share by Regions 2018
        Table Market Top Trends
        Table Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Spinal Muscular Atrophy Market Share by Manufacturers (2013-2018)
        Figure Global Spinal Muscular Atrophy Market Share by Manufacturers in 2018
        Table Global Spinal Muscular Atrophy Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Spinal Muscular Atrophy Product/Solution/Service
        Table Date of Enter into Spinal Muscular Atrophy Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table Global Spinal Muscular Atrophy Market Size Share by Type (2013-2018)
        Figure Global Spinal Muscular Atrophy Market Size Market Share by Type (2013-2018)
        Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table Global Spinal Muscular Atrophy Market Size Share by Application (2013-2018)
        Figure Global Spinal Muscular Atrophy Market Size Market Share by Application (2013-2018)
        Figure Global Spinal Muscular Atrophy Revenue Market Share by Application in 2017
        Figure United States Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table United States Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table United States Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table United States Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table United States Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table United States Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Figure Europe Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table Europe Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table Europe Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table Europe Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table Europe Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table Europe Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table Europe Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Figure China Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table China Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table China Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table China Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table China Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table China Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table China Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Figure Japan Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table Japan Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table Japan Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table Japan Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table Japan Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table Japan Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Figure Southeast Asia Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table Southeast Asia Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Figure India Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table India Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table India Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table India Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table India Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table India Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table India Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Figure Central & South America Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Spinal Muscular Atrophy Market Share (2017-2018)
        Table Central & South America Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Spinal Muscular Atrophy Market Share by Type (2013-2018)
        Table Central & South America Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Spinal Muscular Atrophy Market Share by Application (2013-2018)
        Table Lonis Pharmaceuticals Company Details
        Table Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) (Million US$)
        Figure Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
        Table Lonis Pharmaceuticals Recent Development
        Table F. Hoffmann-La Roche Company Details
        Table F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
        Figure F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
        Table F. Hoffmann-La Roche Recent Development
        Table AveXis Company Details
        Table AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
        Figure AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
        Table AveXis Recent Development
        Table Novartis Company Details
        Table Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
        Figure Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
        Table Novartis Recent Development
        Table Cytokinetics Company Details
        Table Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
        Figure Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
        Table Cytokinetics Recent Development
        Table Ionis Pharmaceuticals Company Details
        Table Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)
        Figure Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)
        Table Ionis Pharmaceuticals Recent Development
        Table Global Spinal Muscular Atrophy Market Size by Regions (Million US$) 2018-2025
        Figure Global Spinal Muscular Atrophy Market Size Share by Regions (2018-2025)
        Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025
        Figure United States Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Figure China Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Figure India Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)
        Table Global Spinal Muscular Atrophy Market Size by Product (2018-2025) (Million US$)
        Figure Global Spinal Muscular Atrophy Market Size by Product (2018-2025)
        Figure Global Spinal Muscular Atrophy Market Size by Product in 2025
        Table Global Spinal Muscular Atrophy Market Size by Application (2018-2025) (Million US$)
        Figure Global Spinal Muscular Atrophy Market Size by Application (2018-2025)
        Figure Global Spinal Muscular Atrophy Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources